Presentation at the 3rd Annual Diabetes Conference in London
Copenhagen, January 15 2007. Bang & Olufsen Medicom, an innovative drug delivery device solutions provider for the pharmaceutical industry, will present at the 3rd Annual Diabetes Conference in London, January 17-19 2007. Health care professionals from all over the world will gather at the conference in London to share and discuss the latest advances within effective insulin delivery and anti-diabetes therapies.
On day two of the conference, Bang & Olufsen Medicom will showcase its lessons learned in moving from a consumer electronics company to a specialist in designing and developing innovative medical devices to the pharmaceutical industry. The presentation will take place on January 18th at 3.40 pm.
International key account manager, Hans-Erik Gording will focus on the therapeutic area of diabetes and will offer a cross-industry perspective on technology development. Mr. Gording will elaborate on what is driving innovation and how Bang & Olufsen Medicom takes advantage of its consumer electronics heritage from Bang & Olufsen when designing and developing medical devices. The presentation will be supported by two case studies; one on how to improve patient compliance and the bottom line by using the Helping HandTM tablet dispenser and the other case detailing the Insulair®, a newbreath-actuated pMDI.
Speaking about the upcoming conference, Mr. Gording said; “The presentation will elaborate on our unique innovation process at Medicom and will demonstrate how our approach enables us to design and develop user-friendly medical devices aimed at improving drug delivery and patient compliance.”
Moreover, attendees can meet Bang & Olufsen Medicom on their exhibitor stand throughout the conference in London, where its novel solutions within effective drug delivery devices will be presented. These includes an innovative injection pen cap with a reminder function, the design award winning intelligent tablet reminder and patient compliance device, the Helping HandTM and the innovative breath-actuated inhaler Insulair® that features an integrated single dose counter and offers a compact design and a cost-effective solution.
About Bang & Olufsen Medicom
Bang & Olufsen Medicom is a leading expert in the design, development and supply of innovative drug delivery device solutions and sensor based technologies. The current product range includes; inhalers, tablet reminders and injection pens with a focus on patient compliance. Bang & Olufsen Medicom offers concept development, engineering and manufacturing services to clients with options to license its intellectual property.
For more information you can visit: http://www.medicom.bang-olufsen.com